Easton Pharmaceuticals (OP: EAPH) Announces Three New Additional Products and a Revision to Its Viorra Flagship Product Towards Resuming Its Latin American & South East Asia Initiatives  
6/10/2013 10:19:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--Easton Pharmaceuticals (OTC:EAPH - News), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products announces that its restructuring of management, business strategy and products has resulted in the company being able to re-start initiatives and discussions on its main Viorra product and the addition of 3 new products for both the North and Latin American markets, including Mexico and various parts of South East Asia.

Help employers find you! Check out all the jobs and post your resume.